PDA

View Full Version : Testing IDO Inhibitors As A Treatment For Cancer: Preclinical Data Support Ongoing Cl

News
07-23-2012, 01:13 AM
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors...

More... (http://www.medicalnewstoday.com/releases/248066.php)